Caina Technology Co 301122.SZ · CNY

Its shares trade on Shenzhen under the ticker 301122.SZ. It has been listed since 26 January 2022. In the fiscal year to 31 December 2025, it reported revenue of CN¥356.7m and net income of CN¥5.6m. At that date it held total assets of CN¥2.01bn and shareholders' equity of CN¥1.84bn.

Caina Technology Co., Ltd. engages in the the business of manufacturing medical consumables. The company is headquartered in Wuxi, Jiangsu. The company went IPO on 2022-01-26. The Company’s main products are puncture needles, syringes, laboratory consumables and masks, including reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposables Sterile syringes, petri dishes, reagent tubes and others. The firm's products are exported to the United States, the United Kingdom, the European Union and other countries and regions.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Jun LuChairman of the Board, General Manager, since 2017CN¥501,000
• Ms. Lingyun ChaFinance Director, Director, since 2017CN¥285,600
• Ms. Hong ZhaoDeputy General Manager, Director, since 2017
• Mr. Lijie ZhaoDeputy General Manager, Director, since 2017CN¥450,500
• Mr. Weiwei LuSecretary of the BoardCN¥15
• Mr. Rufa ChengDirectorCN¥320,500
• Ms. Rong GaoIndependent DirectorCN¥20,800
• Mr. Bin LiuIndependent Director
• Mr. Shanghu WangIndependent DirectorCN¥20,800
• Mr. Liyang XiaIndependent DirectorCN¥20,800

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.